Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients
- V. Pirags
- , H. Lebovitz
- , P. Fouqueray
- Paula Stradina Clinical University Hospital
- Poxel SA
Research output: Contribution to journal › Article › peer-review
121
Scopus
citations